首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Gynecologic oncology reports

缩写:

ISSN:2352-5789

e-ISSN:2352-5789

IF/分区:1.5/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引1828
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Lauren M Lim,Sarah L Speck,Yingao Zhang et al. Lauren M Lim et al.
Background: Isolated ovarian metastasis in otherwise early-stage cervical cancer is an extremely rare clinical scenario. According to the 2018 International Federation of Gynecology and Obstetrics, ovarian involvement doe...
Yachai Li,Jiarui Mi,Peixuan Wang et al. Yachai Li et al.
Background: Endometrial cancer co-occurring with a pelvic ectopic kidney is an extremely rare condition. To prevent accidental intraoperative injury to the ectopic kidney and its aberrant vasculature, digital model obtain...
Grace Getman,Taryn Boucher,Vicki Keedy et al. Grace Getman et al.
Background: Ecthyma gangrenosum (EG) is a rare necrotizing skin infection most commonly associated with Pseudomonas in immunocompromised patients. Increasingly, EG has been identified in nonbacteremic or immunocompetent p...
Ravi Desai,Cyrus Jalai,Pelin Onur et al. Ravi Desai et al.
Background: Gestational choriocarcinoma (GC) is a rare but highly aggressive form of gestational trophoblastic neoplasia with a strong propensity for early hematogenous spread. Most cases arise within the uterus; extraute...
Christine I Cho,Anne-Laure Strong,Brooke Arner et al. Christine I Cho et al.
Objective: The impact of pre-operative frailty on outcomes in patients with endometrial cancer is not well studied. The primary aim of this study was to assess the association between preoperative frailty scores and posto...
Halle Petrie,Taryn Boucher,Marta A Crispens et al. Halle Petrie et al.
Introduction: Anaphylaxis to carboplatin and paclitaxel are important and potentially life-threatening events that can disrupt chemotherapeutic treatment of gynecologic cancers. Using the FDA Adverse Event Report System (...
Heena Arshad,Inamullah Arshad,Hamza Massab Rehman et al. Heena Arshad et al.
Endometrial, ovarian, and cervical cancers in advanced or recurrent stages are associated with unfavorable outcomes, emphasizing the need for effective targeted approaches. While HER2 has been identified as a key biomarker in selected high-...
Rachel P Mojdehbakhsh,Ryan J Spencer,Natalia Gontarczyk Uczkowski et al. Rachel P Mojdehbakhsh et al.
Objectives: The second largest government funding source for cancer research is the Department of Defense (DOD). The Peer Reviewed Cancer Research Program (PRCRP) is the funding mechanism for uterine cancer under the DOD....
C L P Muntinga,A J van de Sande,M J P Welters et al. C L P Muntinga et al.
Objective: The topical immune modifier imiquimod is used as alternative treatment for cervical high-grade squamous intraepithelial lesions (cHSIL). While its clinical efficacy in primary cHSIL (pcHSIL) is approximately 60...
Wissam Arab,Nadine El Kassis,Clement Khoury et al. Wissam Arab et al.
Brain metastases from epithelial ovarian cancer (EOC) are uncommon and usually occur during disease recurrence. Their occurrence at the initial phase of the disease is particularly rare. Overall prognosis remains poor despite the employment...